๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Overexpression of aldo-keto reductase 1C2 is associated with disease progression in patients with prostatic cancer

โœ Scribed by Kuo-Hsuan Huang; Shiow-Her Chiou; Kuan-Chih Chow; Tze-Yi Lin; Hui-Wen Chang; I-Ping Chiang; Meng-Chih Lee

Book ID
108780944
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
461 KB
Volume
57
Category
Article
ISSN
0309-0167

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

TENB2, a proteoglycan identified in pros
TENB2, a proteoglycan identified in prostate cancer that is associated with disease progression and androgen independence
โœ Eveline Glynne-Jones; Maureen E. Harper; Liam T. Seery; Rhianedd James; Ian Angl ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 258 KB

TENB2 encodes a putative transmembrane proteoglycan, related to the EGF/heregulin family of growth factors and follistatin, which has been identified through the application of a differential display technique to a xenograft model of prostate cancer. Northern analysis and competitive PCR were used t

Elevation of serum levels of urokinase-t
Elevation of serum levels of urokinase-type plasminogen activator and its receptor is associated with disease progression and prognosis in patients with prostate cancer
โœ Miyake, Hideaki; Hara, Isao; Yamanaka, Kazuki; Gohji, Kazuo; Arakawa, Soichi; Ka ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 175 KB ๐Ÿ‘ 1 views

BACKGROUND. Several investigators have revealed that urokinase-type plasminogen activator (uPA) and its receptor (uPAR) are overexpressed in serum as well as in tumor tissues in patients with various types of cancer. In this study, we examined whether the serum levels of uPA and uPAR could be used a